Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10491803 | 0.87 | VKORC1 (0.41) | VKORC1TYRKMT2AHIF1AMEN1 | |
| SCHEMBL5507568 | 0.87 | VKORC1 (0.41) | VKORC1TAAR1TYRKMT2ALMNA | |
| SCHEMBL9782878 | 0.84 | MEN1 (0.44) | VKORC1TYRKMT2AHIF1AKDM4E | |
| SCHEMBL9782879 | 0.84 | L3MBTL1 (0.42) | VKORC1TAAR1TYRKMT2ALMNA | |
| SCHEMBL9770025 | 0.83 | VKORC1 (0.41) | VKORC1TAAR1TYRKMT2AADRA2A | |
| SCHEMBL11040190 | 0.83 | VKORC1 (0.53) | VKORC1TYRKMT2AADRA2AADRA2C | |
| SCHEMBL866448 | 0.81 | VKORC1 (0.38) | VKORC1TYRKMT2ACYP2D6MEN1 | |
| SCHEMBL30569963 | 0.80 | VKORC1 (0.39) | VKORC1TAAR1TYRKMT2AADRA2A | |
| SCHEMBL169730 | 0.80 | TAAR1 (0.50) | TAAR1TYRKMT2AADRA2AADRA2C | |
| SCHEMBL7499823 | 0.80 | TAAR1 (0.50) | TAAR1TYRKMT2AADRA2AADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3597670-B1 | WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE | ADEKA CORP (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-11649334-B2 | Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate | ADEKA CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| US-11036135-B2 | Curable composition, cured product thereof, and curing method therefor | ADEKA CORPORATION (JP) | 2021-06-15 | — | — | US | disclosed |
| US-20210079252-A1 | COATING COMPOSITION | ADEKA CORPORATION (JP) | 2021-03-18 | — | — | US | disclosed |
| US-20200123371-A1 | WATER-SOLUBLE COMPOSITION AND CURED PRODUCT THEREOF | ADEKA CORPORATION (JP) | 2020-04-23 | — | — | US | disclosed |
| EP-3640307-A1 | COATING COMPOSITION | Adeka Corporation (JP) | 2020-04-22 | — | — | EP | disclosed |
| US-20200073239-A1 | CURABLE COMPOSITION, CURED PRODUCT THEREOF, AND CURING METHOD THEREFOR | ADEKA CORPORATION (JP) | 2020-03-05 | — | — | US | disclosed |
| US-20200032021-A1 | WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE | ADEKA CORPORATION (JP) | 2020-01-30 | — | — | US | disclosed |
| EP-3546492-A1 | CURABLE COMPOSITION, CURED PRODUCT THEREOF, AND CURING METHOD THEREFOR | Adeka Corporation (JP) | 2019-10-02 | — | — | EP | disclosed |
| EP-3228641-B1 | CURABLE COMPOSITION | TOKYO OHKA KOGYO CO LTD (JP) | 2019-07-03 | — | — | EP | disclosed |
| US-7247886-B2 | Organic EL light emitting display device and method of manufacturing the same | KABUSHIKI KAISHA TOSHIBA (JP) | 2007-07-24 | — | — | US | disclosed |
| US-20060226421-A1 | Amine compound and uses thereof | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KENKYUJO (JP) | 2006-10-12 | — | — | US | disclosed |
| US-7081320-B2 | High energy density secondary battery for repeated use | CANON KABUSHIKI KAISHA (JP) | 2006-07-25 | — | — | US | disclosed |
| US-20050062050-A1 | Organic EL light emitting display device and method of manufacturing the same | KABUSHIKI KAISHA TOSHIBA. | 2005-03-24 | — | — | US | disclosed |
| EP-1006119-B1 | NOVEL CRYSTALLINE ION-ASSOCIATION SUBSTANCE, PROCESS FOR PRODUCING THE SAME, AND LATENT PHOTOPOLYMERIZATION INITIATOR | AUTEX INC (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6395423-B1 | FILM COVERING OF ELECTRODE | CANON KABUSHIKI KAISHA (JP) | 2002-05-28 | — | — | US | disclosed |
| US-6391492-B1 | OXIDATION OF TITANIUM, VANADIUM, CHROMIUM, MANGANESE, IRON, COBALT, NICKEL OR COPPER BY REACTION TRANSITION METAL COMPOUND WITH WATER, ALCOHOL, OR HYDROXIDE; LITHIUM BATTERIES; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 2002-05-21 | — | — | US | disclosed |
| US-6387975-B1 | ORGANOMETALLIC COMPOUND COMPLEX | AUTEX, INC. (JP) | 2002-05-14 | — | — | US | disclosed |
| US-6207326-B1 | ANODES AND CATHODES WITH NITROGEN AND HALOGEN | CANON KABUSHIKI KAISHA (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-1006119-A1 | NOVEL CRYSTALLINE ION-ASSOCIATION SUBSTANCE, PROCESS FOR PRODUCING THE SAME, AND LATENT PHOTOPOLYMERIZATION INITIATOR | AUTEX, INC. (JP) | 2000-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060226421-A1 | Amine compound and uses thereof | PNMT, TYR, PAM | VKORC1 3339/4885TAAR1 256/4885TYR 2/4885 |
| US-20200032021-A1 | WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE | PHOSPHO1, ASS1, SGMS1 | VKORC1 3122/4885TAAR1 2839/4885TYR 3802/4885 |
| US-11649334-B2 | Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate | PHOSPHO1, ASS1, SGMS1 | VKORC1 3122/4885TAAR1 2839/4885TYR 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.